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Development and validation of a simplified 
algorithm for neonatal gestational age assessment 
– protocol for the Alliance for Maternal Newborn 
Health Improvement (AMANHI) prospective 
cohort study
Objective The objective of the Alliance for Maternal and 
Newborn Health Improvement (AMANHI) gestational age 
study is to develop and validate a programmatically feasible 
and simple approach to accurately assess gestational age of 
babies after they are born. The study will provide accurate, 
population–based rates of preterm birth in different settings 
and quantify the risks of neonatal mortality and morbidity 
by gestational age and birth weight in five South Asian and 
sub–Saharan African sites.
Methods This study used on–going population–based co-
hort studies to recruit pregnant women early in pregnancy 
(<20 weeks) for a dating ultrasound scan. Implementation 
is harmonised across sites in Ghana, Tanzania, Zambia, Ban-
gladesh and Pakistan with uniform protocols and standard 
operating procedures. Women whose pregnancies are con-
firmed to be between 8 to 19 completed weeks of gestation 
are enrolled into the study. These women are followed up to 
collect socio–demographic and morbidity data during the 
pregnancy. When they deliver, trained research assistants 
visit women within 72 hours to assess the baby for gesta-
tional maturity. They assess for neuromuscular and physical 
characteristics selected from the Ballard and Dubowitz mat-
uration assessment scales. They also measure newborn an-
thropometry and assess feeding maturity of the babies. Com-
puter machine learning techniques will be used to identify 
the most parsimonious group of signs that correctly predict 
gestational age compared to the early ultrasound date (the 
gold standard). This gestational age will be used to catego-
rize babies into term, late preterm and early preterm groups. 
Further, the ultrasound–based gestational age will be used 
to calculate population–based rates of preterm birth.
Importance of the study The AMANHI gestational age 
study will make substantial contribution to improve identi-
fication of preterm babies by frontline health workers in 
low– and middle– income countries using simple evalua-
tions. The study will provide accurate preterm birth esti-
mates. This new information will be crucial to planning and 
delivery of interventions for improving preterm birth out-
comes, particularly in South Asia and sub–Saharan Africa.
www.jogh.org •  doi: 10.7189/jogh.07.021201	 1	 December 2017  •  Vol. 7 No. 2 •  021201
V
IE
W
PO
IN
TS
PA
PE
RS
AMANHI et al.
December 2017  •  Vol. 7 No. 2 •  021201	 2	 www.jogh.org •  doi: 10.7189/jogh.07.021201
Accurately identifying preterm births around the time of delivery increases opportunities for using tar-
geted high impact interventions to reduce mortality and morbidity but requires that gestational age at 
birth be known. Preterm birth is a global challenge affecting both developed and developing countries 
[1,2]. It contributes annually to approximately 35% of neonatal and 75% of perinatal mortality world-
wide [3–5]. In addition, survivors suffer long–term respiratory, gastrointestinal and neurodevelopmental 
morbidities with consequences on health, growth, psychosocial functioning and economic viability in 
later life [6–8]. The greatest burden of mortality and morbidity from preterm births occur in low and 
middle income settings (LMICs) [9]. In 2005, almost 13 million children were born preterm and 85% of 
these occurred in Africa and Asia [10].
Interventions that are feasible to implement and have the potential to prevent or help manage preterm 
birth complications in LMICs exist, but their effectiveness has not been rigorously evaluated [11]. The 
critical step to deploying such interventions is identification of preterm births. In high–income settings, 
early pregnancy ultrasound is used to enhance accurate gestational age estimation. Preterm births are 
therefore anticipated right at the onset of labour and interventions such as antenatal corticosteroids are 
administered to improve outcomes. In contrast, pregnancy ultrasound for assessing gestational age is of-
ten not available or affordable to women in LMICs [12]. Pregnant women also seek care quite late; by 
which time most ultrasound scans do not yield reliable gestational age estimates. To help frontline health 
workers identify preterm babies for targeted interventions, simpler methods of gestational age assessment 
are needed.
One option is to train them to identify preterm babies immediately after they are born. The Ballard [13,14] 
and Dubowitz [15,16] scoring systems use physical and neuromuscular signs to estimate newborn ges-
tational maturity after birth. Whilst they are potentially feasible to implement in LMICs, they are rarely 
used at scale partly because they have not been rigorously evaluated in comparison with a reliable “gold 
standard” or because they include too many component signs that are difficult to assess on all babies. For 
instance, five [14,17–20] of six studies that evaluated the accuracy of these scores compared them with 
women’s last menstrual period (LMP) that is itself not reliable for gestational age assessment. Meanwhile, 
portable ultrasound machines are now available, relatively cheap and can be deployed to allow improved 
gestational age assessment at population level or within research settings in LMICs. In addition, advanc-
es in computer programming and “machine learning” methods enable simpler algorithms with equivalent 
validity to be derived from complex patterns and inter–relationships between signs.
The Alliance for Maternal and Newborn Health Improvement (AMANHI) gestational age study is being 
implemented in five countries in South Asia and sub–Saharan Africa. It aims to develop and validate sim-
ple, programmatically feasible methods (using non–clinically–trained research workers) to accurately as-
sess gestational age of babies at the population level in comparison to early pregnancy ultrasound (gold 
standard). The study will also use these accurate gestational ages to evaluate the risk of mortality and 
morbidity, by gestational age, among neonates. This manuscript describes the protocol for the harmonized 
implementation of the study.
METHODOLOGY
Study design
The AMANHI gestational age study is a multi–centre, population–based prospective development and 
evaluation of the diagnostic accuracy of simple methods for gestational age assessment (including report-
ed LMP, physical, neuromuscular, feeding assessments and anthropometry). These will be compared with 
gestational age from early pregnancy ultrasound scans. The Maternal, Newborn, Child and Adolescent 
Health department of the World Health Organization (WHO/MCA) is coordinating the study.
Objectives
The objective of the AMANHI gestational age study is to develop and validate a programmatically feasible 
and simple approach to accurately assess the gestational age of babies after they are born. The study will 
provide accurate, population–based rates of preterm birth in different settings and quantify the risks of 
(i) neonatal mortality by gestational age and birthweight, and (ii) maternal and neonatal morbidity by 
gestational age from population–based pregnancy cohorts.
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Study settings
Five sites in South Asia (Sylhet, Bangladesh and Karachi, Pakistan) and sub–Saharan Africa (Kintampo, 
Ghana; Pemba, Tanzania; and Southern Province, Zambia) are using harmonized protocols to implement 
the AMANHI gestational age study. Across the sites, study populations are predominantly rural with low 
literacy levels. Health facilities of various types provide a range of services from basic to comprehensive 
emergency obstetric and newborn care. All sites, except Zambia, have an on–going one to three–month-
ly community–based pregnancy surveillance in which trained fieldworkers conduct home visits to all 
women of reproductive age to identify pregnancies for enrolment and follow–up until the end of preg-
nancy. In Zambia, the study is recruiting pregnant women at antenatal clinics.
Identifying eligible pregnancies and obtaining consent
Eligibility. Trained fieldworkers use a variety of methods to identify pregnant women for the study. Wom-
en either directly report their pregnancies or the fieldworkers elicit missed periods from women’s report-
ed dates of their LMP. They also conduct pregnancy tests, if required, to confirm pregnancies. In Zambia, 
over 96% of all pregnant women attend antenatal care (ANC) clinics so study participants are recruited 
from these clinics. The study enrols women only if their pregnancies are between 8–19 completed weeks 
by ultrasound examination. This window ensures that pregnancies are early enough to give accurate ul-
trasound gestational age estimates but also excludes very early pregnancy losses due to genetic or chro-
mosomal abnormalities. Enrolled women should also be willing to be available for the gestational age as-
sessment to be conducted on their babies within 72 hours after birth.
Consenting. Fieldworkers consent pregnant women, in their local or preferred languages, to undergo a 
screening ultrasound examination to establish gestational age and subsequently enrol women if eligibil-
ity is confirmed (pregnancies between 8–19 weeks’ gestation). Consent for additional procedures varies 
slightly across sites. In Ghana, for instance, fieldworkers obtain initial consent for the screening ultra-
sound. They only consent eligible women after scan and again before the gestational age assessment when 
the baby is born. In other sites, women are comprehensively consented at the initial contact to cover the 
scan and follow–up. In Zambia in case the pregnant woman is a “minor” between 15 years to 18 years, 
assent is first obtained from women themselves before their legal guardians provide written informed 
consent for their participation.
Harmonization of implementation
Uniform protocols are being used across sites to conduct the screening ultrasound scan, pregnancy fol-
low–up, newborn gestational age assessments and quality assurance. The principal investigators from the 
sites, WHO/MCA team and selected global newborn experts supported the development of these proto-
cols for use at all sites. Centralised training sessions were organised for investigators from the sites to en-
sure harmonised implementation.
Standard operating procedures
Principal investigators from the sites developed generic standard operating procedures (SOP) for imple-
menting the study. This document outlines the strategy for implementation as illustrated in Figure 1. In 
summary, it specifies that the gold standard gestational age will be derived from an early pregnancy ul-
trasound scan (<20 weeks) conducted as part of the study by trained study staff. The study enrols preg-
nant women during the gestational age window of 8 to 19 completed weeks. Biometric parameters mea-
sured include fetal crown–rump length (CRL), bi–parietal diameter (BPD) and femur length (FL) as 
appropriate. Trained non–clinical workers conduct the gestational age assessment of newborns. With this 
cadre of workers, the AMANHI gestational age study ensures that minimally trained frontline health work-
ers can implement postnatal gestational age assessment, at scale. A common manual for implementation 
and core variable table have been developed, which contains modules on the standards for the dating ul-
trasound, newborn gestational age assessment and data collected during follow–up home visits.
Centralised standardised training and validation of trainers for newborn assessment
AMANHI organised a 3–day training of trainers in Sylhet (Bangladesh) for two physician participants from 
each site, using the AMANHI gestational age study manual. The training, coordinated by WHO/MCA, 
aimed to standardize these participants for harmonised implementation across sites. Two experts, a WHO 
Medical Officer in newborn health (AM) and a paediatrician specialist in newborn maturity assessment 
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(ACL) facilitated the training. It involved theoretical instructions, videos and practice sessions. After show-
ing videos of the assessment, the facilitators demonstrated the assessment modalities to the participants 
on mannequins, with emphasis on the assessment principles. Participants in turn practiced on these man-
nequins to acquaint themselves with the assessment modalities. The last two days of training involved 
practice at the paediatric ward of the Osmani Medical College in Sylhet. The trainers again demonstrated 
assessments to participants using newborn babies on the wards. They supervised the participants to take 
turns, practicing initially with term and later with preterm babies. Participants were closely supervised 
and provided additional support to ensure that they became confident and proficient in the assessments. 
For the proficiency validation and standardization, each participant independently assessed five or more 
babies and recorded their findings. Trained facilitators also independently assessed these same babies and 
the findings were compared with the participants. Participants were only certified as having attained mas-
tery for any particular sign if their assessment findings did not vary by more than one point from the find-
ings from the independent assessment by the facilitators.
Ultrasonography for accurately dating pregnancies (gold standard data)
The SOP for the AMANHI gestational age study specifies standardized procedures for measuring fetal 
biometric parameters, and was developed in consultation with a maternal–fetal medicine specialist (BJW). 
Scanning is strictly trans–abdominal. When a potential participant comes to a scanning centre to have 
her pregnancy date assessed, the choice of which biometric parameter to measure depends on the esti-
mated gestational age; this was to ensure that gestational ages estimated from these parameters have the 
highest precision (Table 1). AMANHI measures only the crown–rump length (CRL) if pregnancy is less 
than 14 weeks, both bi–parietal diameter (BPD) and femur length (FL) if more than 14 weeks and all 
three if within the 14th week. Three measurements are independently taken and recorded for each pa-
rameter. Pregnancies that are less than 8 weeks are re–scheduled for repeat scans after four weeks. Wom-
en with pregnancies at 20 weeks or more are counselled to continue routine antenatal clinic attendance 
but are not enrolled into the AMANHI gestational age study. Major abnormalities or intra–uterine fetal 
deaths are promptly referred to health facilities for appropriate management.
Quality control. The team developed a common checklist, in consultation with the MFM expert and 
with adaptations from other international ultrasound quality guidelines [21], which specifies the mini-
Figure 1. Flow diagram showing overview of the AMANHI gestational age study.
AMANHI et al.
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mum acceptable quality standards for measuring each biometric parameter (Table 2). This checklist serves 
as a reference (and harmonization) document for the sonographers at the sites as well as a yardstick for 
independent assessment of image quality and includes guidance on appropriate image zooming, obtain-
ing the correct plane and placement of callipers.
Key quality control measures include:
i.  The MFM expert independently reviews all images taken for 20 among the first 50 study participants 
recruited in each site and provides direct feedback on each individual image and the overall perfor-
mance of sonographers. She also makes recommendations on how to further improve image quality.
ii. Checking images throughout the duration of enrolment;
 –  Images taken for 10% of participants are randomly selected and sent to a specialist sonographer (local 
to each site but independent of the AMANHI study team) for review. This independent sonographer 
provides direct feedback to inform refresher–training needs of study sonographers within each site.
 –  Images taken for 5% of participants are randomly selected and sent for central review and validation 
by the MFM expert (BJW).
Morbidity and birth outcome surveillance
Trained surveillance fieldworkers visit women in their homes, immediately after enrolment, to collect 
baseline socio–demographic, medical and obstetric histories. They make three antenatal visits at 24–28 
weeks, 32–36 weeks and after 38 weeks to collect data on morbidity and mortality during the pregnancy 
and pregnancy outcomes using the common core variable table. Women’s blood pressure is measured and 
their urine is tested for proteins. In some sites, women’s symphysis–fundal height is also measured. Dur-
ing these visits, fieldworkers establish a birth notification system so that families will notify the study 
whenever the pregnancy ends – irrespective of the outcome. For live births, immediately after the notifi-
cation, research assistants are dispatched to reach babies and conduct AMANHI gestational age assess-
ment within 72 hours of birth. The surveillance fieldworkers also increase their frequency of home visits 
to all women whose pregnancies are 28 weeks or older and leave their phone numbers for families to 
contact them whenever the pregnancy ends. When any pregnancy ends, additional home visits are made 
to ascertain the status of newborns and mothers at the end of the first 28 and 42 to 60 days, days respec-
tively. For every maternal, fetal or neonatal death, a verbal autopsy form is completed to obtain detailed 
information on the circumstances leading to the death; causes of death are assigned by trained and AMAN-
Table 1. Choice of fetal biometric parameter by estimated gestational age in AMANHI
Gestational aGe of fetus What biometric parameter to measure
8 weeks 0 days – 13 weeks 6 days Crown–rump length only
14 weeks 0 days – 14 weeks 6 days Crown–rump length, bi–parietal diameter & femur length
15 weeks 0 days and beyond Bi–parietal diameter and femur length
Table 2. Indicators for ensuring optimal quality of ultrasound images for each biometric parameter
Quality modality biometric parameter
Crown rump length Bi–parietal diameter Femur length
Zooming Good magnification
(50% of image size)
Good magnification
(50% of image size)
Good magnification
(50% of image size)
Frozen in 
correct plane
Neutral position–not hyper-
flexed or hyperextended
Skull is oval and bone visible 
throughout
Femur imaged side–to–side on 
screen
Fetus horizontal  
(side–to–side on screen)
Thalamus is visible Only one bone in this portion of 
extremity
Full extent of crown visible Skull side to side on screen Upper femur measured
Full extent of rump visible Full extent of femur visualized 
(solid straight line)
Caliper 
placement
Crown caliper at edge of head Calipers placed perpendicular to 
long axis of skull
Calipers placed at edge of echogenic 
bone (outer to outer)
Rump caliper placement at 
lower spine
Top caliper placed on outer 
portion of the skull
Secondary ossification centres not 
measured
Bottom caliper placed on inner 
portion of skull
Validation of gestational age assessment protocol for a prospective study
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HI–accredited physicians. The accreditation process involves training for harmonized assignment of causes 
of deaths and passing of a centralised standardised test conducted by the WHO [22].
Newborn assessment
Assessors. Non–clinician field workers (at supervisory grade and with ³10 years formal education) were 
trained and standardized to conduct the AMANHI newborn gestational age assessments. These assessors 
are blinded to babies’ ultrasound–estimated gestational ages.
Inclusion and exclusion criteria. The assessors screen for newborn illnesses before conducting the new-
born assessment. Families are engaged throughout the assessment process. The assessors ask to know 
about the families’ perception on the general health of the newborn. If babies are reportedly unwell, they 
use the newborn assessment module of WHO’s integrated management of childhood illness (IMCI) guide-
lines to assess severity. Babies with severe illness are excluded and referred to health facilities for care. 
Even if the family thinks the baby is well but the assessors consider them unwell, they also refer to health 
facilities for care. In general, assessors advise care–seeking at health facilities even when the IMCI algo-
rithm shows the newborn is not ill but the family thinks otherwise.
Assessment modalities. Table 3 shows signs being assessed for in the AMANHI gestational age study. 
These signs were selected based on a systematic literature review for evidence of their use in assessing 
newborn gestational maturity and a pragmatic consideration of how easily they could be assessed by front-
line health workers. There are six neuromuscular signs which test passive flexor tone or flexibility and 10 
physical signs. The physical and neuromuscular signs were selected from the original Ballard score [14]. 
Each sign relates to a particular body part (eg, skin), under which are sub–categories such as colour, opac-
ity, texture, etc. The separate sub–categories were adapted from the Dubowitz score [15,16] because they 
are separated and relatively easier to differentiate. After discussions with Dubowitz (personal communi-
cation), ankle dorsiflexion was added to the neuromuscular signs as a measure of joint flexibility. The 
“square window” sign was dropped due to parental concerns during piloting.
Seven anthropometric measures (head, chest and mid–upper arm circumference, infant length, birth 
weight, breast–bud diameter, infant foot length and (optionally) women’s symphysis–fundal height) in 
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Table 3. Assessment modalities with acceptable precision (for anthropometric measurements)
assessment siGns precision (if applicable)
Neuro–muscular 
signs
• Posture
• Arm recoil
• Scarf sign
• Popliteal angle
• Heel–to–ear test
• Ankle dorsiflexion
Physical signs • Skin: colour, texture, opacity and presence of lanugo
• Ear: shape and recoil
• Breast: nipple–areola development
• Male genitalia: testes and scrotum
• Female genitalia: labia and clitoris
• Foot: plantar creases
Anthropometry • Head circumference (cm) ±0.5 cm
• Chest circumference (cm) ±0.5 cm
• Breast bud diameter (mm) ±1 mm OR ±0.1 cm
• Mid–upper arm circumference (cm) ±2 mm OR ±0.2 cm
• Foot length (mm) ±2 mm OR ±0.2 cm
• Infant length (cm) ±0.5 cm
• Symphysis–fundal height (cm) ±1.0 cm
• Weight (g) ±40 g if digital scale & 100 g if suspension scale
Feeding •  Check whether the infant is able to attach well to the breast by observing four 
signs: mouth open; lower lip everted; chin touching the breast below; greater 
part of the areola in mouth and more areola seen above than below.
•  Observation: Suckling behaviour of the baby at the breast – deep, slow con-
tinuous suck with swallowing in between or shallow quick sucks.
•  Observe: Duration the infant was able to stay attached to the breast continu-
ously during the feed?
•  Observation: The longest continuous burst of suckling (number of sucks)
•  While observing breastfeeding, how many times did the baby suck before swal-
lowing?
AMANHI et al.
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pregnancy are taken. Foot length (right foot) is measured from base of the heel to the tip of the halux, 
based on methods proposed by Marchant et al [23]. For all the measurements, two are taken indepen-
dently and if their difference exceeds a set acceptable margin of error (Table 3), a third measurement is 
taken. All three measurements are recorded. Five signs of feeding maturity, adapted from WHO’s infant 
feeding assessment guide with additions (on suckling bursts and suck–to–swallow ratios) from the Nvquist 
[24] preterm feeding questionnaire are also assessed. Assessors record their findings on a standard AMAN-
HI form.
Supervision of assessment
This involves direct observation, scheduled and un–scheduled visits to study assessors. Study coordina-
tors supervise assessors on the field. They directly observe 5% of assessments conducted by the Research 
Assistants in the communities as part of the supervision. These 5% selected observations are spread over 
the entire duration of the study to ensure assessors’ skills are being maintained. The coordinators have 
been purposively selected from a pool of supervisors who have performed excellently in previous engage-
ments as supervisors in the sites. Their qualifications range from post–secondary to university graduates. 
As well as their extensive previous experience in field research, they were provided additional training in 
the conduct of the gestational age assessment and then on how to supervise and provide feedback to the 
assessors. The coordinators also make scheduled and unscheduled visits to assessors in the field to ob-
serve their work. In Tanzania and Ghana, geographical information systems are used to locate assessors 
for these supervisory visits. After each supervisory visit session, feedback on performance is provided to 
the assessor.
In some sites including Ghana, a pilot implementation phase followed the assessors’ training during which 
the study clinician/trainer conducted intensive supervision of assessors and directly observed five or more 
of their newborn assessments. That phase was also used to train field coordinators on the practicality of 
supervising the assessors.
Professional clinician validation of assessment
In order to validate the assessment by the non–clinicians, a trained professional clinician/trainer indepen-
dently validates a random 5–15% sub–sample of assessments conducted by the assessors. In some sites, 
the process is centrally coordinated and an automated system or a study coordinator selects these babies, 
informs the physician of the deliveries and provides them with women’s location to facilitate the valida-
tion assessment. The physician visits the woman at the place of delivery, also within 72 hours, to inde-
pendently assess babies using the AMANHI assessment forms.
Study materials/equipment
The AMANHI gestational age study teams procured uniform equipment and materials for the study across 
sites. Where materials could not be procured from a common source, the desired quality was specified 
in order to provide comparable error margins. Weighing scales, non–stretchable measuring tapes, trans-
parent rulers and infantometers were procured and are used for the assessment across sites.
Supportive activities
In all the sites, the AMANHI study built on existing long–standing relationship of trust and mutual re-
spect between investigators, communities and health facilities. They held meetings with community mem-
bers (and their leaders) to introduce the study and to enhance acceptability of assessments. Separate ori-
entation sessions were organised in health facilities to solicit their support and discuss the potential impact 
of the AMANHI gestational age study on facility workload. These included discussions on referral of com-
plicated pregnancies for appropriate management. In some sites, a separate training was conducted for 
facility staff to assess selected physical signs on babies considered too sick to be assessed by the non–cli-
nician assessors.
Sample size estimation
Previously pooled data from the participating sites showed that approximately 10% of all births were pre-
term. In the AMANHI gestational age study, it was assumed that the simpler methods will detect this 
prevalence with ±5% (absolute) precision and achieve 80% sensitivity and specificity in comparison to 
the early pregnancy ultrasound gestational age estimate. With an additional 1.5–fold adjustment for de-
www.jogh.org •  doi: 10.7189/jogh.07.021201	 3	 December 2017  •  Vol. 7 No. 2 •  021201
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sign effect (to account for contextual differences between study sites) and 
20% attrition rate (due to abortions/miscarriages, stillbirths, early neona-
tal deaths and losses to follow–up) [25], a minimum of 5740 pregnant 
women will be required to be enrolled. Machine learning approaches use 
separate pools of data from the same population for the identification of 
the algorithm (two thirds of total) and for the validation of this algorithm 
(one third of total). This increases the total targeted sample size to 8610, 
5740 for machine learning and 2870 for validation. Table 4 shows pro-
posed sample size contributions from each site.
Data processing and management
All data are double–entered by two independent clerks at all sites except in Zambia, where they are 
scanned directly using TeleForms software (Hewlett Packard, Sunnyvale, CA). Principal investigators in 
the sites have excellent track records for management of large volumes of data with stringent protocols. 
They are locally responsible for maintaining the data quality in their sites, running range and consistency 
checks and conducting periodic reviews of distributions of the responses to identify outliers in the data 
to address promptly. The WHO/MCA also developed a data quality checking programme to be applied 
on all data to supplement the routine checks conducted by individual sites. Any inconsistencies were 
flagged and resolved in consultation with data managers and investigators from the sites.
Plan for data analysis
The pooled data from the study sites will be split into equal thirds. Computer machine learning tech-
niques will be employed on two–thirds of the data to find a group of signs that accurately and indepen-
dently predicts gestational age or identifies preterm babies <34 weeks and/or <37 weeks compared to 
ultrasound dates (gold standard). The difference in gestational age estimates (in completed weeks) be-
tween the gold standard and the simpler methods (LMP and/or newborn assessments) will be plotted 
against the mean gestational ages (of gold standard and simplified method). Any identified algorithm that 
meets the requisite validity criteria will then be applied to the remaining one–third of data to assess va-
lidity (sensitivity, specificity and receiver operating characteristic curves).
Predicted gestational ages from the new algorithm will be used to categorize babies into those <34 weeks, 
34–36weeks and those ³37 weeks or a dichotomy of preterm (<37 weeks) vs term. Chance–corrected 
agreement and kappa statistics will be generated between these categories and those obtained from ges-
tational age cut–offs based on ultrasound dating and interpreted using Landis and Koch [26] criteria. Re-
gression models will also be fitted to determine association between gestational age and adverse maternal 
and neonatal outcomes. Analyses will be done using Stata® Version 14.0 (StataCorp., Tx, USA) and oth-
er specialized software.
Ethical considerations
All study protocols have been approved by ethical review committees of the WHO and appropriate insti-
tutions in each of the participating sites.
Dissemination of study findings
Study findings will be shared promptly with the Technical Steering Committee comprising the WHO/
MCA coordinating team, the principal investigators from the five sites and the Bill & Melinda Gates Foun-
dation. Local dissemination meetings will be held with community members, policy–makers, health man-
agers and administrators in all sites. A detailed implementation evaluation report, including lessons 
learned will be shared with the WHO and Gates Foundation. Policy briefs on outcomes will be dissemi-
nated nationally and internationally to relevant policy and donor organisations. Study findings will also 
be disseminated in scientific/technical forums and in peer–reviewed journals.
CONTRIBUTION OF THE AMANHI GESTATIONAL AGE STUDY TO 
PRETERM BIRTH IDENTIFICATION
We described the design, organization and implementation strategy of a harmonized study to identify a 
suitable algorithm comprising simple signs that could be feasibly used by frontline workers to accurately 
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Table 4. Study sites and contribution to the 
overall study sample
study sites minimum sample 
size contribution 
from study sites
Bangladesh (Sylhet) 2200
Ghana (Kintampo) 1000
Pakistan (Karachi) 2200
Tanzania (Pemba) 2200
Zambia (Southern Province, Zambia) 1000
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predict gestational age. If successful, this method comprising simple signs that do not require intense 
clinical training to assess, will help health workers in lower level facilities to identify preterm births in 
these settings where the results will be most relevant (South Asia and sub–Saharan Africa). The results of 
this study will contribute to mechanisms of targeting interventions aimed at reducing risk of death and 
significant disability from complications of preterm birth in LMICs [8,27].
The AMANHI gestational age study has many strengths: it is being conducted in five countries in South 
Asia and sub–Saharan Africa and has adequate power to yield very precise estimates on the validity of 
these simpler methods; it is one of the few LMIC studies with early ultrasound dating as the gold stan-
dard; it targets the identification of preterm babies at the population/community level with large sample 
size, using non–clinician research workers rather than health professionals in health facilities. The find-
ings will therefore be feasible to implement programmatically at first level facilities or in communities by 
frontline workers with the barest minimum of professional clinical training. Since many of these preterm 
births are born at home [28–30] or in these lower level facilities in many LMICs, equipping this cadre of 
staff with a tool to identify preterm births will be a significant step towards ensuring survival and well–
being of preterm babies because tested interventions can be deployed in time for their care.
Despite these strengths, the study also has potential challenges. First, with many deliveries occurring at 
home, it may be possible that assessors will not be able to reach babies within the narrow 72–hour win-
dow particularly since social seclusion after delivery (where women and the babies are secluded from 
public for up to 40 days) is pervasive in these settings [31–34]. Second excluding babies who are deemed 
“unwell” may selectively bias the assessments towards term babies because preterm babies are more like-
ly to be perceived as unwell by families and hence assessments may not be done. If assessments are main-
ly conducted on term babies, component signs may lose their discriminatory power to identify preterm 
babies. The study sites are therefore using innovative methods to reach babies immediately after they are 
born. These methods include providing incentives to families for prompt birth notification, regular phone 
calls to women around term and increasing frequency of home visits to women whose pregnancies were 
older than 34 weeks. In some sites, selected nurses within health facilities are trained to conduct full as-
sessments on babies who are apparently unwell and cannot be examined by research workers. These 
nurses use the same forms being used by the AMANHI research assistants. If babies are truly unwell to 
undergo the full assessments, a select limited number of physical signs and anthropometric measures are 
assessed by these nurses.
In conclusion, if successful, the AMANHI gestational age study will make a significant contribution to 
improving the ability of frontline health workers in LMICs to accurately assess gestational age in order to 
discriminate preterm from term infants. This will allow for more effective targeting of interventions for 
preterm babies in order to improve their survival. Although identification of preterm babies is the most 
crucial step for now in the planning and delivery of interventions, it remains only the first step and must 
be accompanied by concurrent deployment of tested interventions to reduce mortality and residual dis-
abilities in survivors.
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